PCM
RXDX

Prelude Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Prelude Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,200
Closed -$773K – 1379
2023
Q1 		$773K Buy
7,200
+4,800
+200% +$515K 0.05% 321
2022
Q4 		$264K Buy
+2,400
New +$264K 0.01% 733